Seizure News and Research

Latest Seizure News and Research

New 100 teraflop supercomputer will help simulation of brain seizures

The U.S. Department of Energy's Argonne National Laboratory will play a major role in the development of a new national computational science facility aimed at deploying a supercomputer capable of sustained performance of 100 trillion floating-point operations per second (teraflops) by 2007.

21 May 2004

Obese women more likely to have pregnancy complications and caesarean sections than women of average weight

The controlled study is one of the largest ever to look at obesity in pregnancy, following more than 16,000 pregnant women at 14 medical centers across the country.

20 May 2004

End-of-life options for seriously ill patients have improved considerably, but still have a ways ago

End-of-life options for seriously ill patients have improved considerably, but still have a ways ago, says a national expert who drew upon the recent experience of his father’s death to take stock of the status of end-of-life care in the United States.

14 May 2004

FDA knocks back King Pharmaceuticals self-injectible epilepsy product

King Pharmaceuticals, Inc. has reported the receipt by its Meridian Technologies subsidiary of a letter from the U.S. Food and Drug Administration

13 May 2004

Publication of epilepsy research

Bionomics Limited has announced today that research by its collaborators Women's and Children's Hospital, in conjunction with the University of Melbourne and a US group in Tennessee, has been published in the scientific journal, Human Molecular Genetics.

13 May 2004

No evidence of CJD associated with the Garden State Racetrack

The Department of Health and Senior Services released a report today on an investigation of a suspected cluster of Creutzfeldt-Jakob Disease (CJD) associated with the Garden State Racetrack.

8 May 2004

New guidelines for using new antiepileptic drugs to treat epilepsy

The number of drugs available to treat epilepsy have more than doubled in the last decade. The American Academy of Neurology and the American Epilepsy Society have assembled the top experts in the field to evaluate the available data of 1,462 research articles in order to create a guideline for the treatment of epilepsy with the new antiepileptic drugs (AEDs).

6 May 2004

Antiepileptic drug Levetiracetam may help patients with Parkinson's disease

In patients with Parkinson's disease, the antiepileptic drug levetiracetam (Keppra(R)) reduced the involuntary movements (dyskinesia) associated with levodopa, the medication most commonly used to treat Parkinson's disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology.

29 Apr 2004

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Two studies presented today at the American Academy of Neurology (AAN) 56th Annual Meeting show that pregabalin, when used as an add-on treatment for epilepsy, does not affect male reproductive function or interfere with the effectiveness of oral contraceptives.

29 Apr 2004

Two outbreaks in humans of deadly Nipah virus in reported Bangladesh

Wildlife Trust's Consortium for Conservation Medicine reports that the World Health Organization (WHO) has now confirmed two recent outbreaks in humans of deadly Nipah virus in Bangladesh. The Consortium has been researching the origins of Nipah virus under a grant from the National Institutes of Health.

28 Apr 2004

People with uncontrolled epilepsy have low levels of a certain fatty acid

Omega-3 fatty acids are crucial to the proper development and function of cell membranes in the brain. But one particular fatty acid, docosahexaenoic acid (DHA), is found at abnormally low levels in patients with uncontrolled epilepsy, according to researchers at Emory University in Atlanta, GA.

28 Apr 2004

Antiepileptic drug levetiracetam (Keppra) shown to help chronic daily headaches

The antiepileptic drug levetiracetam (Keppra(R)) significantly reduced the frequency and impact of headaches in patients diagnosed with transformed migraine, according to a new study presented today at the 56th annual meeting of the American Academy of Neurology (AAN).

27 Apr 2004

A ten year study shows that surgery is not only effective, but the preferred treatment for select epilepsy patients

A study of ten years of patient outcomes shows that surgery is not only effective, but the preferred treatment for select epilepsy patients. In the most comprehensive study of long-term surgery success rates, Mayo Clinic physicians report that 73 percent of 491 Mayo Clinic patients were either seizure-free or experienced seizures only when medication was discontinued.

27 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

NICE issues guidance on use of newer drugs for epilepsy in adults

The National Institute for Clinical Excellence (NICE) has today issued guidance to the NHS in England and Wales on the use of newer drugs for the treatment of epilepsy in adults.

26 Apr 2004

Foreign drug repackager complies with FDA order

The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.

13 Apr 2004

FDA issues warning againts street drug alternatives

FDA issued a warning in February 2004, about adverse events experienced by four teenagers after they consumed Green Hornet Liquid that contained high levels of the over-the-counter drugs diphenhydramine and dextromethorphan.

11 Apr 2004

Natural medication shown to not always be a safe alternative to synthetic medication

The common perception that if medication is natural then it must be safe has recently come under fire from a researh by a Consumer Reports magazine. The consumer publication found a dozen herbal supplements, some banned in Asia, Europe and Canada but widely available in the United States, may cause cancer, kidney or liver damage and even death.

10 Apr 2004

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

The largest study of its kind, designed to track the development of Creutzfeldt-Jakob disease in people who received human growth hormone from cadavers, has found that the vast majority of those who received the hormone did not contract the fatal condition. However, some recipients (26 out of approximately 7,700) did develop the disease.

7 Apr 2004

New research findings in study of Rett Syndrome

Rudolf Jaenisch of the Whitehead Institute of Biomedical Research in Cambridge, MA reports in the April 6, 2004 online issue of the Proceedings of the National Academy of Sciences that introduction of the MeCP2 protein into post-mitotic nerve cells of MeCP2 mutant mice rescues the symptoms of Rett Syndrome. This raises the possibility that neurons are functionally normal in a newborn child and that neural dysfunction manifests itself only later due to prolonged MeCP2 deficiency. If correct, therapeutic strategies aimed at preventing the onset of Rett symptoms could be initiated at birth.

7 Apr 2004